QA: ABBOTT LABORATORIES in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000001800_2019_ABBOTT_LABORATORIES.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000001800, ABBOTT LABORATORIES

  xvar xval
0 AssetsCurrent 14,632,000,000
1 IntangibleAssetsNetIncludingGoodwill 42,196,000,000
2 PropertyPlantAndEquipmentNet 7,563,000,000
3 remainder_Assets 2,782,000,000
4 LiabilitiesCurrent 9,012,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 12,706,000,000
8 SellingGeneralAndAdministrativeExpense 9,744,000,000
9 ResearchAndDevelopmentExpense 2,300,000,000
10 remainder_Expenses 3,543,000,000
11 remainder_Revenues 30,578,000,000
12 remainder_NetIncome 83,000,000
13 remainder_ComprehensiveNetIncome -1,192,000,000
  yvar yval
0 Assets 67,173,000,000
1 Liabilities 9,012,000,000
2 Expenses 28,293,000,000
3 Revenues 30,578,000,000
4 StockholdersEquity 58,161,000,000
5 NetIncome 2,368,000,000
6 ComprehensiveNetIncome 1,772,000,000
7 BaseVar 68,165,500,000
8 EconomicCapitalRatio 2.67

Edgar->Model Mapping

Feature Distribution

Change over Time